Atsushi Nomoto

Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Keizo Sogabe, Hisataka Nirei, Miwako Shoubo et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 222 citations

Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine

Atsushi Nomoto, Seitaro Mutoh, Hiroyuki Hagihara et al. · Atherosclerosis · 1988 · 106 citations

Inflammation, Mechanobiology, Skeletal Muscle +10

Inflammatory responses in cuff-induced atherosclerosis in rabbits

Jiro Hirosumi, Atsushi Nomoto, Y. Ohkubo et al. · Atherosclerosis · 1987 · 82 citations

Inflammation, Inflammatory Responses, Immunology +5

Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist

Atsushi Nomoto, Jiro Hirosumi, Chie Sekiguchi et al. · Atherosclerosis · 1987 · 78 citations

Antiatherogenic Activity, Medicine, Physiology +3

Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery

Hiroyuki Hagihara, Atsushi Nomoto, Seitaro Mutoh et al. · Atherosclerosis · 1991 · 41 citations

Inflammation, Thrombosis, Inflammatory Responses +12